about
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditisSomatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell linemiR-15a and miR-16-1 down-regulation in pituitary adenomasMagmas, a gene newly identified as overexpressed in human and mouse ACTH-secreting pituitary adenomas, protects pituitary cells from apoptotic stimuliPlasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope.Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system.Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders?Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds.Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancerSomatostatin receptors: from basic science to clinical approach--thyroid.Hypopituitarism after traumatic brain injury.Antiproliferative effects of somatostatin analogs in pituitary adenomas.In vitro testing of new somatostatin analogs on pituitary tumor cells.Systemic illness.Thyroid papillary microcarcinoma: a descriptive and meta-analysis study.MicroRNAs and possible role in pituitary adenoma.Primary empty sella: Why and when to investigate hypothalamic-pituitary function.Pituitary side effects of old and new drugs.The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells.Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells.N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis.Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines.Rare diseases in clinical endocrinology: a taxonomic classification system.Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids.miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ.Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression.Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitro.Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors.Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids.Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model.Effect of everolimus on cell viability in nonfunctioning pituitary adenomas.Growth hormone excess promotes breast cancer chemoresistance.Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro.Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma.Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT.
P50
Q21131390-09FB2F1E-F652-4E7B-A964-FF6437A66EECQ28204929-B4EC1CE4-9BA4-475A-9DA0-D98284104210Q28302259-32B5550B-FEA1-4BF0-99A8-B1BC471E0BE5Q28587831-30E1691B-EBB1-4D3D-89DD-C4BF691884BDQ33148706-EE958D3E-0D46-4BE9-B6A8-2C196389E83CQ33217109-612D35FE-82E6-4223-BE99-EE012DB1B297Q33233913-905AAD72-B399-47DF-B930-F8D723727E14Q34584688-5E92D997-DC1A-4481-8297-D8E45D5F773AQ34616528-7BC318B3-B415-472A-9B5C-DC7CD5F566B7Q35064835-F99D3B71-7529-408A-B779-1BA0D2C73C46Q35743409-777C7E9E-812A-4B3E-B70D-DED873D93FAAQ36119344-C22DC2DF-118B-4DBE-9FB4-84BABF80133EQ36480174-70FF2E02-4AD9-4962-9933-4B73B3867987Q37075120-065F3B19-A2E0-4BEE-8D75-4632F4C35073Q37135443-FACAB379-93E3-4E8E-96B6-A268FD1E0A7BQ37247453-4DB2E76F-DEFA-4D12-A8BF-F705FF13EDDEQ37308219-C4656B24-5261-4D51-8FB2-85BF8F1EBC4BQ37704168-9FC25265-280A-4352-98B6-E2D7B40E8C88Q38234756-BD2A9842-C57F-4979-BB46-F9A972E6223EQ38889681-EDB7EAD6-3B2D-40E0-BF90-388029007084Q38968381-12995EA4-A69F-47B7-BF31-B6EEDF426E93Q39001526-1D4BDCAB-57EC-4804-87AC-220E01EB2E5DQ39028227-07E8930C-4266-4FA4-B25E-39D1A0D219CDQ39102141-1063D21A-020F-42E1-B812-A73A5ADBF1CFQ39132665-034505F5-EB84-43D5-A841-741980836463Q39154831-FD817D83-9C41-44CD-B1F0-667507208293Q39176386-D9D0107D-A8CF-40A5-8D5B-4BCB0B748A35Q39375005-B2556AE0-10C9-40A8-88DF-3EFAC695970DQ39388406-A55165D6-2193-41DE-985E-28810818F09CQ39537737-4D76AC33-6612-443F-83A8-0D058BF23264Q39691959-AC22E2DA-990D-4E21-BB70-15EC42F4E084Q39714806-06255542-581A-4DA8-B417-0FF35F017E71Q39766349-1923BA6D-97F5-4D41-A925-F5481BE3FBAAQ39822484-CCE5C192-D5B6-46C8-ACE9-31CEB19CE88EQ40043203-9406D52B-F110-4B04-B4C4-C9BA9397E661Q40294769-3F2EB10F-C954-4AA1-ABF9-41530EA89B7EQ40298829-2D27FA0A-AE79-4C20-8DA7-3173B7AD1748Q40386924-EF631327-BBB6-4D00-800B-FB0B00566E2DQ40450845-BF704087-E73E-4872-812F-8B2D0D9F252CQ40725391-837D9D3E-63B0-4A41-BF8F-E03057D1533C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ettore C degli Uberti
@ast
Ettore C degli Uberti
@en
Ettore C degli Uberti
@es
Ettore C degli Uberti
@nl
Ettore C degli Uberti
@sl
type
label
Ettore C degli Uberti
@ast
Ettore C degli Uberti
@en
Ettore C degli Uberti
@es
Ettore C degli Uberti
@nl
Ettore C degli Uberti
@sl
prefLabel
Ettore C degli Uberti
@ast
Ettore C degli Uberti
@en
Ettore C degli Uberti
@es
Ettore C degli Uberti
@nl
Ettore C degli Uberti
@sl
P106
P1153
35413536700
P21
P31
P496
0000-0002-9441-7223